KAITY MOLENDA: Open Payments
NPI 1982183661 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,612 in 115 payments from 16 companies in 2025. Trend: 2023 $2,032 · 2024 $3,320 · 2025 $1,612
Food & beverage: $1,612
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $268 |
| GENZYME CORPORATION | 9 | $261 |
| Novartis Pharmaceuticals Corporation | 35 | $194 |
| Amgen Inc. | 9 | $167 |
| Janssen Biotech, Inc. | 10 | $161 |
| UCB, Inc. | 9 | $140 |
| PFIZER INC. | 7 | $137 |
| Lilly USA, LLC | 4 | $71 |
| LEO Pharma Inc. | 2 | $54 |
| Incyte Corporation | 2 | $40 |
Products named: DUPIXENT, OTEZLA, SKYRIZI, TREMFYA, Bimzelx, CIBINQO, RINVOQ, COSENTYX.
Industry payments across NY — which companies pay providers there.
